1普通概念尽早的诊断、围手术期处置的发展以及患者选择的优化使得肝切除术后肝细胞性肝癌患者的生存率提高[1]。在过去20年,美国肝癌生存率已经提高一倍[2]。手术切除和原位肝移植(OLT)是肝癌的两种最常用根治性疗法。对进展期肝硬化和符合移植标准的肿瘤,无肝外转移,无大血管侵犯的肝细胞肝癌患者,实行肝移植是治疗的金标准,因为可同时治疗肿瘤和潜在的肝硬化。对于具备良好肝功能储备(Child-Pugh分级A级和早期Child- 1 Early diagnosis of general concepts, development of perioperative management, and optimization of patient selection have led to an increased survival rate of patients with hepatocellular carcinoma after hepatectomy [1]. Over the past 20 years, the United States has doubled the survival rate of liver cancer [2]. Surgical resection and orthotopic liver transplantation (OLT) are two of the most commonly used radical therapies for liver cancer. Liver transplantation for advanced cirrhosis and meet the standard tumor, no extrahepatic metastases, no major vascular invasion of hepatocellular carcinoma patients, the implementation of liver transplantation is the gold standard for treatment, because the tumor can be treated and potential cirrhosis. For patients with good liver function reserve (Child-Pugh grade A and early Child-